1 study found for:    TYROSINEMIA, TYPE II
Show Display Options
Rank Status Study
1 Completed Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I
Condition: Tyrosinemia, Type I
Intervention: Drug: NTBC

Indicates status has not been verified in more than two years